Insufficient scRNA-seq data for expression of UGT3A2 at single-cell level.
Insufficient scRNA-seq data for expression of UGT3A2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 69% | 92.69 | 61 / 89 | 16% | 1.77 | 147 / 901 |
skin | 71% | 633.95 | 1284 / 1809 | 9% | 0.69 | 42 / 472 |
spleen | 49% | 50.37 | 117 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 44% | 1.82 | 35 / 80 |
liver | 6% | 3.88 | 14 / 226 | 28% | 2.93 | 113 / 406 |
adrenal gland | 6% | 5.45 | 15 / 258 | 25% | 9.44 | 58 / 230 |
thymus | 0% | 0.07 | 1 / 653 | 25% | 5.51 | 153 / 605 |
ovary | 0% | 0 | 0 / 180 | 21% | 0.64 | 91 / 430 |
uterus | 1% | 0.29 | 1 / 170 | 20% | 1.81 | 92 / 459 |
breast | 0% | 0.22 | 2 / 459 | 19% | 1.55 | 211 / 1118 |
bladder | 0% | 0 | 0 / 21 | 17% | 1.07 | 87 / 504 |
lung | 0% | 0.30 | 2 / 578 | 16% | 1.21 | 190 / 1155 |
esophagus | 0% | 0 | 0 / 1445 | 13% | 0.65 | 23 / 183 |
prostate | 5% | 3.22 | 13 / 245 | 6% | 0.15 | 30 / 502 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.14 | 3 / 29 |
peripheral blood | 6% | 5.29 | 58 / 929 | 0% | 0 | 0 / 0 |
brain | 3% | 2.76 | 88 / 2642 | 1% | 0.04 | 10 / 705 |
stomach | 0% | 0.12 | 1 / 359 | 4% | 0.15 | 12 / 286 |
intestine | 1% | 0.50 | 7 / 966 | 4% | 0.27 | 19 / 527 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
heart | 2% | 1.46 | 14 / 861 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.06 | 2 / 178 |
adipose | 0% | 0.69 | 5 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.71 | 4 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.06 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071412 | Biological process | cellular response to genistein |
GO_0043541 | Cellular component | UDP-N-acetylglucosamine transferase complex |
GO_0015020 | Molecular function | glucuronosyltransferase activity |
GO_0008194 | Molecular function | UDP-glycosyltransferase activity |
Gene name | UGT3A2 |
Protein name | UDP-glucuronosyltransferase 3A2 (UDPGT 3A2) (EC 2.4.1.17) UDP glycosyltransferase family 3 member A2 |
Synonyms | UNQ842/PRO1780 PSEC0073 |
Description | FUNCTION: UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds (By similarity). . |
Accessions | D6RDU1 ENST00000515131.1 ENST00000504685.5 ENST00000513300.5 [Q3SY77-2] Q3SY77 ENST00000282507.8 [Q3SY77-1] D6RHY1 |